Rznomics Inc. Secures Fast Track Designation from the U.S. FDA for RZ-001

SEONGNAM-SI, South Korea , Nov. 10, 2023 /PRNewswire/ — Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA)…